These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 3146398

  • 1. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
    Sturgess NC, Kozlowski RZ, Carrington CA, Hales CN, Ashford ML.
    Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
    [Abstract] [Full Text] [Related]

  • 2. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y, Anello M, Henquin JC.
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells.
    Lee K, Ozanne SE, Hales CN, Ashford ML.
    Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407
    [Abstract] [Full Text] [Related]

  • 6. RIN14B: a pancreatic delta-cell line that maintains functional ATP-dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatin.
    Bränström R, Höög A, Wahl MA, Berggren PO, Larsson O.
    FEBS Lett; 1997 Jul 14; 411(2-3):301-7. PubMed ID: 9271225
    [Abstract] [Full Text] [Related]

  • 7. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A, Zünkler BJ, Lenzen S.
    Biochem Pharmacol; 1989 Apr 15; 38(8):1217-29. PubMed ID: 2650685
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.
    Zünkler BJ, Lenzen S, Männer K, Panten U, Trube G.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb 15; 337(2):225-30. PubMed ID: 2452991
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line.
    Dunne MJ, Illot MC, Peterson OH.
    J Membr Biol; 1987 Feb 15; 99(3):215-24. PubMed ID: 2447283
    [Abstract] [Full Text] [Related]

  • 12. Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle.
    Faivre JF, Findlay I.
    Biochim Biophys Acta; 1989 Aug 21; 984(1):1-5. PubMed ID: 2504288
    [Abstract] [Full Text] [Related]

  • 13. Diazoxide- and leptin-activated K(ATP) currents exhibit differential sensitivity to englitazone and ciclazindol in the rat CRI-G1 insulin-secreting cell line.
    Harvey J, Ashford ML.
    Br J Pharmacol; 1998 Aug 21; 124(7):1557-65. PubMed ID: 9723971
    [Abstract] [Full Text] [Related]

  • 14. Dual effects of diazoxide on ATP-K+ currents recorded from an insulin-secreting cell line.
    Kozlowski RZ, Hales CN, Ashford ML.
    Br J Pharmacol; 1989 Aug 21; 97(4):1039-50. PubMed ID: 2676059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.
    Trube G, Rorsman P, Ohno-Shosaku T.
    Pflugers Arch; 1986 Nov 21; 407(5):493-9. PubMed ID: 2431383
    [Abstract] [Full Text] [Related]

  • 17. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino MG, Plant TD, Henquin JC.
    Br J Pharmacol; 1989 Nov 21; 98(3):957-65. PubMed ID: 2531623
    [Abstract] [Full Text] [Related]

  • 18. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide.
    Ball AJ, Flatt PR, McClenaghan NH.
    Eur J Pharmacol; 2000 Nov 24; 408(3):327-33. PubMed ID: 11090651
    [Abstract] [Full Text] [Related]

  • 19. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
    Schöfl C, Börger J, Mader T, Waring M, von zur Mühlen A, Brabant G.
    Am J Physiol Endocrinol Metab; 2000 Apr 24; 278(4):E639-47. PubMed ID: 10751197
    [Abstract] [Full Text] [Related]

  • 20. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
    Cosgrove KE, Antoine MH, Lee AT, Barnes PD, de Tullio P, Clayton P, McCloy R, De Lonlay P, Nihoul-Fékété C, Robert JJ, Saudubray JM, Rahier J, Lindley KJ, Hussain K, Aynsley-Green A, Pirotte B, Lebrun P, Dunne MJ.
    J Clin Endocrinol Metab; 2002 Nov 24; 87(11):4860-8. PubMed ID: 12414839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.